Article citationsMore>>

Joensuu, H., Eriksson, M., Sundby Hall, K., Hartmann, J.T., Pink, D., Schütte, J., et al. (2012) One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor. JAMA, 307, 1265-1272.
https://doi.org/10.1001/jama.2012.347

has been cited by the following article:

• TITLE: Case Report: Intermediate-Risk Gastrointestinal Stromal Tumor (GIST) of the Jejunum with Postoperative Gastroparesis

  AUTHORS: Vithiarithy Chey, Neang Nov, Koung Tep, Chhay Reaksmey, Vitou Leang, Dimanche Chhit, Theanlong Chea, Tortry Tan, Pich Udom Tuy, Tharuom Ny, Polen Te, Phanit Prom, Keoseyla Unn, Syphanna Sou

  KEYWORDS: Gastrointestinal Stromal Tumor, GIST, Jejunum, Gastroparesis, Gastrojejunostomy, Case Report

  JOURNAL NAME: Open Journal of Gastroenterology, Vol.16 No.7, July 23, 2026

  ABSTRACT: We report a case of a 43-year-old female with a history of breast cancer who was diagnosed with an intermediate-risk gastrointestinal stromal tumor (GIST) of the jejunum. The patient underwent successful en bloc tumor resection with duodenojejunal anastomosis. She later developed postoperative gastroparesis, requiring gastrojejunostomy. This report highlights diagnostic challenges, surgical management, and postoperative complications in jejunal GIST.